IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.1759
-0.0156 (-8.15%)
At close: Mar 16, 2026, 4:00 PM EDT
0.1689
-0.0070 (-3.98%)
After-hours: Mar 16, 2026, 7:58 PM EDT
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $12.66 million as of March 16, 2026. Its market cap has decreased by -79.67% in one year.
Market Cap
12.66M
Enterprise Value
24.46K
1-Year Change
-79.67%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $12.66M, a decrease of -96.57%. That is a compound annual growth rate of -53.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 12.66M | -71.11% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 14.56M |
| Cocrystal Pharma | 14.20M |
| Polyrizon | 14.02M |
| Phio Pharmaceuticals | 13.59M |
| Cellectar Biosciences | 13.57M |
| BioCardia | 13.37M |
| GT Biopharma | 13.08M |
| CalciMedica | 13.07M |